Description: Kasten, Inc. is a biopharmaceutical company focused on the acquisition, development, and commercialization of pharmaceuticals and devices designed to prevent and treat serious conditions arising in the hospital and adjacent clinical settings. We are principally focused on delivering solutions to those wards in which the care pathway is burdened by high morbidity, mortality, and cost. Our initial goal is to market the first-in-class in situ product for the prevention of surgical site infections in abdominal surgeries.
522 North Main Avenue
Sioux Falls,
SD
57104
United States
Phone:
888-679-3679
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |